Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accounts Payables (2016 - 2026)

Rockwell Medical filings provide 16 years of Accounts Payables readings, the most recent being $2.0 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 30.32% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 30.32% decrease, with the full-year FY2025 number at $2.0 million, down 30.32% from a year prior.
  • Accounts Payables hit $2.0 million in Q4 2025 for Rockwell Medical, up from $1.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $5.9 million in Q2 2023 to a low of $1.5 million in Q2 2025.
  • Median Accounts Payables over the past 5 years was $3.5 million (2021), compared with a mean of $3.6 million.
  • Biggest five-year swings in Accounts Payables: soared 101.46% in 2023 and later plummeted 60.87% in 2025.
  • Rockwell Medical's Accounts Payables stood at $3.7 million in 2021, then grew by 8.4% to $4.1 million in 2022, then grew by 11.42% to $4.5 million in 2023, then plummeted by 36.47% to $2.9 million in 2024, then plummeted by 30.32% to $2.0 million in 2025.
  • The last three reported values for Accounts Payables were $2.0 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.